About uMed
uMed is a company based in London (United Kingdom) founded in 2018 by Matt Wilson. uMed has raised $17.39 million across 2 funding rounds from investors including Delin Ventures, AlbionVC and Playfair. uMed offers products and services including ACCESS Cohort Studies, AccessPD, AccessCMD, AccessILD, and Recruit. uMed operates in a competitive market with competitors including Carta Healthcare, Verana Health, Clearsense, ClearDATA and Truveta, among others.
- Headquarter London, United Kingdom
- Founders Matt Wilson
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Umedeor Ltd
- Date of Incorporation 16 Nov, 2017
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$17.39 M (USD)
in 2 rounds
-
Latest Funding Round
$12.45 M (USD), Series A
Jul 05, 2023
-
Investors
Delin Ventures
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of uMed
uMed offers a comprehensive portfolio of products and services, including ACCESS Cohort Studies, AccessPD, AccessCMD, AccessILD, and Recruit.
Platform for building and accessing patient cohorts for health studies.
Tool for Parkinson's disease patient data and research insights.
Platform for cardiovascular disease cohort management and analysis.
System for interstitial lung disease patient data collection.
Service for enrolling patients into research studies remotely.
People of uMed
Unlock access to complete
Unlock access to complete
Funding Insights of uMed
uMed has successfully raised a total of $17.39M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $12.45 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in uMed
uMed has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Delin Ventures, AlbionVC and Playfair.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Delin Ventures is engaged in investing and building companies in life sciences and technology sectors.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on investing in tech startups
|
Locked | Locked | Locked | |
|
A venture capital firm focused on pre-seed investments in Europe.
|
Locked | Locked | Locked |
Investor details for uMed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by uMed
Investment portfolio details for uMed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - uMed
Detailed financials for uMed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Umed Comparisons
Peer comparison for uMed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of uMed
uMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Carta Healthcare, Verana Health, Clearsense, ClearDATA and Truveta, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-driven clinical data management tools are offered to healthcare providers.
|
|
| Locked | Locked | Locked |
Verana Health is focused on real-world data analytics in healthcare.
|
|
| Locked | Locked | Locked |
Healthcare analytics platforms and applications are developed for clinicians.
|
|
| Locked | Locked | Locked |
Cloud-based clinical data management platform for healthcare providers
|
|
| Locked | Locked | Locked |
Healthcare data platform for learning services is provided.
|
|
| Locked | Locked | Locked |
Provider of an AI-based medical data management and mining platform for the healthcare industry
|
Detailed competitors of uMed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Umed
Complete news archive for uMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about uMed
uMed was founded in 2018 and raised its 1st funding round 2 years after it was founded.
uMed is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Matt Wilson is the current CEO of uMed. They have also founded this company.
uMed is a funded company, having raised a total of $17.39M across 2 funding rounds to date.
Founded in 2018 in London, United Kingdom, uMed operates in the healthcare technology sector. A collaborative platform is offered for managing clinical data in research and healthcare applications. Precision patient engagement is enabled for research and care programs through healthcare providers. Real-time patient involvement is supported across multiple programs at no extra cost. Research organizations can submit collaboration requests to providers for joint initiatives.
uMed's top competitors include Carta Healthcare, Truveta and ClearDATA.
uMed offers ACCESS Cohort Studies, AccessPD, AccessCMD, AccessILD, and Recruit.
uMed has 4 investors. Key investors include Delin Ventures, AlbionVC, Playfair, and 11.2 Capital.